Related Experiment Video
Updated: May 17, 2026
08:56
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
[2011: What's new in dysimmune neuropathies]
1Unité nerf-muscle, département des neurosciences cliniques, CHU Vaudois, 413 rue du Bugnon, Lausanne, Switzerland. thierry.kuntzer@chuv.ch
Revue Neurologique
|October 31, 2012
Summary
Research advances in dysimmune neuropathies show new therapies for Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies. Biomarkers and novel treatments like monoclonal antibodies are under investigation for improved patient outcomes.
Area of Science:
- Neuroscience and Immunology
- Peripheral Nervous System Disorders
Context:
- Significant research is ongoing in dysimmune neuropathies, impacting conditions like Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies.
- Current diagnostic methods are being re-evaluated, highlighting the need for novel biomarkers such as gene expression patterns and histological findings.
Purpose:
- To review recent advancements in understanding the pathophysiology of dysimmune neuropathies.
- To explore emerging diagnostic tools and therapeutic strategies for Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies.
Summary:
- New pathophysiological insights into Guillain-Barré syndrome are paving the way for novel therapies, including optimized intravenous immunoglobulin (Ig) dosages and clinical prediction models.
- For chronic inflammatory demyelinating polyneuropathies, research focuses on identifying biomarkers from nerve/skin biopsies and exploring treatments like monoclonal antibodies and oral immunosuppressants.
- Advances in MRI imaging of peripheral nerves and the utility of serum antibodies are also being investigated.
Impact:
- Potential for earlier diagnosis and more effective, targeted treatments for patients with dysimmune neuropathies.
- Development of new therapeutic avenues, drawing parallels with successful treatments in multiple sclerosis.
- Improved understanding of disease mechanisms may lead to better patient stratification and management strategies.
More Related Videos
08:57In Vitro Myelination of Peripheral Axons in a Coculture of Rat Dorsal Root Ganglion Explants and Schwann Cells
Published on: February 10, 2023
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...